Dehalogenation method and application of 9-halogenated steroid compounds
Through the reaction of compound I with hydrogen donor and azo radical initiator, the environmental pollution problem caused by the use of heavy metals in the prior art is solved, and a green and environmentally friendly 9-halogenated steroid compound dehalogenation method is realized, which improves the Production suitability and safety.
Patent Information
- Application Number
- CN201910652680.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-29
- Filing Date
- 2019-07-19
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2039-07-19
AI Technical Summary
The existing dehalogenated 9-halosteroid compounds use heavy metal raw materials, which leads to high environmental pollution and environmental protection management costs, limiting the normal application of such reactions.
Compound I reacts with a hydrogen donor and an azo radical initiator to obtain a 9-position dehalogenated product of a 9-halosteroid compound, which is selected from hypophosphoric acid, formic acid, silicone hydride or hydrazine compound. The initiator is selected from azo radicals, and the use of highly toxic agents such as chromium, divalent chromium salt, trivalent chromium salt or hydrogenated tributyltin is avoided.
It realizes a green and environmentally friendly dehalogenation method, which is simple and easy to implement, improves production applicability and safety factor, and avoids serious pollution to the environment.
Smart Images

Figure BDA0002135789960000021 
Figure BDA0002135789960000031 
Figure BDA0002135789960000041
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of chemical synthesis, and in particular to a dehalogenation method and application of a 9-halogenated steroid compound. Background Art
[0002] Corticosteroid drugs have multiple pharmacological effects such as anti-inflammatory, anti-allergic, anti-shock and immunosuppression, so corticosteroid drugs are widely used in the treatment of skin diseases. A key step in the chemical synthesis method of this type of drug is the dehalogenation reaction of 9-halogenated steroid compounds. The more conventional dehalogenation method in the prior art is to add 9-halogenated steroid compounds to a solvent, and react with chromium, divalent chromium salts, trivalent chromium salts or tributyltin hydride at a certain temperature to generate a dehalogenated product. Most of the above processes use heavy metal raw materials, toxic raw materials, etc., which cause serious pollution to the environment, high environmental protection management costs or use of restricted raw materials; thus limiting the normal application of such reactions and affecting the normal production of such products.
[0003] In view of this, the present invention is proposed. Summary of the invention
[0004] The main purpose of the present invention is to provide a dehalogenation method and application of a 9-halogenated steroid compound, in order to at least partially solve at least one of the above technical problems.
[0005] As one aspect of the present invention, the present invention provides a method for dehalogenating a 9-halogenated steroid compound, comprising the following steps: reacting a compound I with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated product compound II at position 9 of the 9-halogenated steroid compound, and the reaction formula is as follows:
[0006]
[0007] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0008] R1=H or methyl;
[0009] R2=H, OH or methyl; R3=H, OH, R6, OR6, OCOR6 or OCOOR6, R6 is an alkyl group with less than 6 carbon atoms;
[0010] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently H or an alkyl group with less than six carbon atoms;
[0011] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0012] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0013] R4=CH2R9, R9=H, OH, halogen or OCOR10, R10 is an alkyl group with less than 6 carbon atoms;
[0014] Or, R4=OCH2R11, R11=halogen;
[0015] Or, R4 = SCH2F;
[0016] R5=H, O, OH, OCOCF3 or OCOR12, R12 is H or an alkyl group with less than 6 carbon atoms;
[0017] X=Cl, Br or I;
[0018] Dashed lines are single or double bonds;
[0019] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0020] Further, the method comprises the following steps: Compound I reacts with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated steroid compound, which is a 9-position dehalogenation product Compound II. The reaction formula is as follows:
[0021]
[0022] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0023] R1=H or methyl;
[0024] R2=H, OH or methyl; R3=H or OH;
[0025] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently H or an alkyl group with less than six carbon atoms;
[0026] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0027] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0028] R4=CH2R9, R9=H, OH or OCOR10, R10 is an alkyl group with less than six carbon atoms;
[0029] R5=H, O, OH, OCOCF3 or OCOR12, R12 is H or an alkyl group with less than 6 carbon atoms;
[0030] X=Cl, Br or I;
[0031] Dashed lines are single or double bonds;
[0032] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0033] Further, the method comprises the following steps: Compound I reacts with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated steroid compound, which is a 9-position dehalogenation product Compound II. The reaction formula is as follows:
[0034]
[0035] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0036] R1=H or methyl;
[0037] R2=H, OH or methyl; R3=H or OH;
[0038] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently methyl groups;
[0039] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0040] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0041] R4=CH2R9, R9=H, OH or OCOR10, R10 is an alkyl group with less than six carbon atoms;
[0042] R5=O, OH, OCOCF3 or OCOR12, R12 is H or methyl;
[0043] X=Cl or Br;
[0044] Dashed lines are single or double bonds;
[0045] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0046] Further, the hypophosphite is selected from sodium hypophosphite and / or potassium hypophosphite;
[0047] and / or, the organosilicon hydride is selected from triphenylsilane;
[0048] And / or, the formate is selected from one or a combination of sodium formate, potassium formate or ammonium formate;
[0049] And / or, the hydrazine compound is selected from hydrazine and / or hydrazine hydrate.
[0050] Furthermore, the azo free radical initiator is selected from one or a combination of azobisisobutyronitrile, azobisisoheptanenitrile, azoisobutylcyanoformamide, azobiscyclohexylcarbonitrile, dimethyl azobisisobutyrate, azobisisobutylimidazole hydrochloride, azobisisopropylimidazoline hydrochloride or azobiscyanovaleric acid.
[0051] Furthermore, the azo free radical initiator is selected from one or a combination of azoisobutylcyanoformamide, azobisisobutylimidazole hydrochloride, azobisisopropylimidazoline hydrochloride or azobiscyanovaleric acid.
[0052] Furthermore, in the reaction, the molar ratio of compound I, azo free radical initiator and hydrogen donor is 1:(0.15-0.4):(1.5-3).
[0053] Further, the method comprises the following steps: adding compound I, a hydrogen donor and an azo free radical initiator into a solvent, reacting at 40-90° C. to obtain compound II, a 9-halogenated steroid compound 9-position dehalogenation product.
[0054] Furthermore, the reaction temperature is 50-85°C.
[0055] Furthermore, an alkali reagent is added to the reaction.
[0056] Furthermore, the alkaline agent is selected from organic bases and / or inorganic bases.
[0057] Furthermore, the organic base is selected from one or a combination of diethylamine, triethylamine, tert-butylamine, pyridine or N,N-diisopropylethylamine.
[0058] Furthermore, the inorganic base is selected from one or a combination of ammonia water, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide.
[0059] Furthermore, the solvent is selected from one or a combination of C1-C6 alcohols, tetrahydrofuran, 2-methyltetrahydrofuran, N,N-dimethylformamide or ethyl acetate, or a mixture thereof with water.
[0060] Furthermore, the solvent is selected from a mixture of C1-C6 alcohols and water.
[0061] As another aspect of the present invention, the present invention provides an application of the above-mentioned dehalogenation method of 9-halogenated steroid compounds in the preparation of corticosteroid drugs and intermediates thereof.
[0062] Furthermore, the corticosteroid drugs include methylprednisolone, methylprednisolone acetate, methylprednisone, methylprednisone acetate, prednisolone, prednisolone acetate, prednisone, cortisone, cortisone acetate, hydrocortisone, hydrocortisone acetate, ciclesonide, budesonide and progesterone.
[0063] The corticosteroid drugs in the present invention include but are not limited to the above drugs.
[0064] Compared with the prior art, the present invention has the following beneficial effects:
[0065] (1) The dehalogenation method of a 9-halogenated steroid compound provided by the present invention comprises reacting a compound I with a hydrogen donor and an azo free radical initiator to obtain a 9-position dehalogenation product compound II of the 9-halogenated steroid compound, wherein the hydrogen donor is one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene, and the initiator is an azo free radical initiator. The reaction does not use chromium, divalent chromium salts, trivalent chromium salts or tributyltin hydride and other reagents with high toxicity and serious environmental pollution. The method is green and environmentally friendly, and the synthesis process is simple and easy to operate, thereby improving the production applicability.
[0066] (2) The present invention uses the dehalogenation method of 9-halogenated steroid compounds to prepare corticosteroid drugs and their intermediates, avoiding the use of chemical reagents with high toxicity and serious environmental pollution in the synthesis route, and has strong operability and high safety factor, thereby improving production applicability. DETAILED DESCRIPTION
[0067] The embodiments of the present invention will be described in detail below in conjunction with the examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific conditions are specified in the examples, conventional conditions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0068] According to the first aspect of the present invention, the present invention provides a method for dehalogenating a 9-halogenated steroid compound, comprising the following steps: reacting a compound I with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated product compound II at position 9 of the 9-halogenated steroid compound, wherein the reaction formula is as follows:
[0069]
[0070] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0071] R1=H or methyl;
[0072] R2=H, OH or methyl; R3=H, OH, R6, OR6, OCOR6 or OCOOR6, R6 is an alkyl group with less than 6 carbon atoms;
[0073] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently H or an alkyl group with less than six carbon atoms;
[0074] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0075] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0076] R4=CH2R9, R9=H, OH, halogen or OCOR10, R10 is an alkyl group with less than 6 carbon atoms;
[0077] Or, R4=OCH2R11, R11=halogen;
[0078] Or, R4 = SCH2F;
[0079] R5=H, O, OH, OCOCF3 or OCOR12, R12 is H or an alkyl group with less than 6 carbon atoms;
[0080] X=Cl, Br or I;
[0081] Dashed lines are single or double bonds;
[0082] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0083] It should be noted that the dotted line between C1 and C2 and the dotted line between R5 and C11 in the structural formula of Compound I and Compound II of the present invention are selected independently of each other, that is:
[0084] When there is a single bond between C1 and C2, R5 and C11 can be connected by a single bond (i.e., R5 = H, OH, OCOCF3 or OCOR12) or by a double bond (i.e., R5 = O, i.e., C11 is a carbonyl group);
[0085] When there is a double bond between C1 and C2, R5 and C11 can be connected by a single bond (ie, R5 = H, OH, OCOCF3 or OCOR12) or by a double bond (ie, R5 = O, i.e., C11 is a carbonyl group).
[0086] The present invention provides a dehalogenation method for a 9-halogenated steroid compound. The method comprises the following steps: a compound I is reacted with a hydrogen donor and an azo free radical initiator to obtain a 9-position dehalogenation product compound II of the 9-halogenated steroid compound. The hydrogen donor is one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene. The initiator is an azo free radical initiator. No reagents such as chromium, divalent chromium salt, trivalent chromium salt or tributyltin hydride, which are highly toxic and cause serious environmental pollution, are used in the reaction. The method is green and environmentally friendly, and the synthesis process is simple and easy to operate, thereby improving the production applicability.
[0087] In a preferred embodiment, the method comprises the following steps: Compound I reacts with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated steroid compound, a 9-position dehalogenation product, Compound II, as shown in the following reaction formula:
[0088]
[0089] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0090] R1=H or methyl;
[0091] R2=H, OH or methyl; R3=H or OH;
[0092] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently H or an alkyl group with less than six carbon atoms;
[0093] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0094] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0095] R4=CH2R9, R9=H, OH or OCOR10, R10 is an alkyl group with less than six carbon atoms;
[0096] R5=H, O, OH, OCOCF3 or OCOR12, R12 is H or an alkyl group with less than 6 carbon atoms;
[0097] X=Cl, Br or I;
[0098] Dashed lines are single or double bonds;
[0099] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0100] In a preferred embodiment, the method comprises the following steps: Compound I reacts with a hydrogen donor and an azo free radical initiator to obtain a 9-halogenated steroid compound, a 9-position dehalogenation product, Compound II, as shown in the following reaction formula:
[0101]
[0102] Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and:
[0103] R1=H or methyl;
[0104] R2=H, OH or methyl; R3=H or OH;
[0105] or, R2, That is, C16 and C17 are also connected by an oxygen bridge, and R7 and R8 are independently methyl groups;
[0106] or, R2, That is, the C16 and C17 positions are also connected by epoxy;
[0107] Or, R2, R3 = single bond, i.e., C16 and C17 are also connected by a double bond;
[0108] R4=CH2R9, R9=H, OH or OCOR10, R10 is an alkyl group with less than six carbon atoms;
[0109] R5=O, OH, OCOCF3 or OCOR12, R12 is H or methyl;
[0110] X=Cl or Br;
[0111] Dashed lines are single or double bonds;
[0112] Wherein, the hydrogen donor is selected from one or a combination of hypophosphorous acid and hypophosphite, formic acid and formate, organosilicon hydride, hydrazine compounds or cyclohexene.
[0113] In a preferred embodiment, the hypophosphite is selected from sodium hypophosphite and / or potassium hypophosphite;
[0114] and / or, the organosilicon hydride is selected from triphenylsilane;
[0115] And / or, the formate is selected from one or a combination of sodium formate, potassium formate or ammonium formate;
[0116] And / or, the hydrazine compound is selected from hydrazine and / or hydrazine hydrate.
[0117] Various types of hydrogen donors include but are not limited to the above reagents, which can avoid the use of highly toxic chemical reagents, have strong operability, high safety factor, are environmentally friendly, and improve production applicability.
[0118] In a preferred embodiment, the azo free radical initiator is selected from one or a combination of azobisisobutyronitrile (AIBN), azobisisoheptanenitrile (ABVN), azoisobutylcyanamide (CABN), azobiscyclohexylcarbonitrile (ACCN), dimethyl azobisisobutyrate (AIBME), azobisisobutylimidazole hydrochloride (AIBA), azobisisopropylimidazoline hydrochloride (AIBI) or azobiscyanovaleric acid (ACVA).
[0119] In a preferred embodiment of this embodiment, the azo free radical initiator is selected from one or a combination of azoisobutylcyanoformamide (CABN), azobisisobutylimidazole hydrochloride (AIBA), azobisisopropylimidazoline hydrochloride (AIBI) or azobiscyanovaleric acid (ACVA).
[0120] In a preferred embodiment, the molar ratio of compound I, azo free radical initiator and hydrogen donor in the reaction is 1:(0.15-0.4):(1.5-3).
[0121] Among them, typical but non-limiting molar ratios of compound I, azo free radical initiator and hydrogen donor are 1:0.3:2, 1:0.15:3, 1:0.4:1.5, 1:0.16:2.8, 1:0.18:2.6, 1:0.2:2.4 or 1:0.25:2.2.
[0122] When the compound I, the azo free radical initiator and the hydrogen donor are in the above molar ratio, the conversion of the compound I can be close to quantitative conversion when the required azo free radical initiator and the hydrogen donor are in appropriate amounts.
[0123] In a preferred embodiment, the method comprises the following steps: adding compound I, a hydrogen donor and an azo free radical initiator into a solvent, reacting at 40-90° C. to obtain compound II, a 9-halogenated steroid compound having a 9-position dehalogenation product.
[0124] Among them, typical but non-limiting temperatures of the reaction can be, for example, 40°C, 42°C, 44°C, 46°C, 48°C, 50°C, 52°C, 54°C, 56°C, 58°C, 60°C, 62°C, 64°C, 66°C, 68°C, 70°C, 72°C, 74°C, 76°C, 78°C, 80°C, 82°C, 84°C, 86°C, 88°C or 90°C.
[0125] The dehalogenation method of 9-halogenated steroid compounds provided by the present invention does not use highly toxic and highly dangerous chemical reagents, has mild reaction conditions, can complete the reaction at 40-90° C., has strong operability, high safety factor, and improves production applicability.
[0126] In a preferred embodiment of this embodiment, the reaction temperature is 50-85°C.
[0127] In a preferred embodiment, an alkaline reagent is also added during the reaction.
[0128] Alkaline reagents can be used as acid binding agents. Their main function is to absorb the hydrogen halide generated during the reaction and also to prevent the reaction solution from being too acidic or too alkaline, thereby maintaining the pH of the reaction solution at 3-9.
[0129] In a preferred embodiment, the alkaline agent is selected from organic bases and / or inorganic bases.
[0130] In a preferred embodiment of this embodiment, the organic base is selected from one or a combination of diethylamine, triethylamine, tert-butylamine, pyridine or N,N-diisopropylethylamine.
[0131] In a preferred embodiment of this embodiment, the inorganic base is selected from one or a combination of ammonia water, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide.
[0132] In a preferred embodiment, the solvent is selected from one or a combination of C1-C6 alcohols, tetrahydrofuran, 2-methyltetrahydrofuran, N,N-dimethylformamide (DMF) or ethyl acetate, or a mixture thereof with water.
[0133] In a preferred embodiment of this embodiment, the solvent is selected from a mixture of C1-C6 alcohols and water.
[0134] The organic solvent used in the prior art is N,N-dimethylformamide or acetone, and the wastewater generated in the post-treatment is about several dozen times the weight of the raw material; the solvent in the present invention includes but is not limited to C1-C6 alcohols, tetrahydrofuran, 2-methyltetrahydrofuran, N,N-dimethylformamide or ethyl acetate, one or a combination of several, or a mixture with water, preferably a mixture of C1-C6 alcohols and water. Compared with the prior art, the use amount of the reaction solvent in the present invention is reduced by more than half, the amount of reaction waste liquid generated is greatly reduced, the cost of raw materials is reduced, and the pressure of environmental protection management is reduced, and it has certain production applicability.
[0135] According to the second aspect of the present invention, the present invention provides an application of the above-mentioned dehalogenation method of 9-halogenated steroid compounds in the preparation of corticosteroid drugs and intermediates thereof.
[0136] The present invention uses the dehalogenation method of 9-halogenated steroid compounds to prepare corticosteroid drugs and intermediates thereof, avoids the use of chemical reagents with high toxicity and serious environmental pollution in the synthesis route, has strong operability, high safety factor, and improved production applicability.
[0137] In a preferred embodiment of this embodiment, the corticosteroid drugs include methylprednisolone, methylprednisolone acetate, methylprednisone, methylprednisone acetate, prednisolone, prednisolone acetate, prednisone, cortisone, cortisone acetate, hydrocortisone, hydrocortisone acetate, ciclesonide, budesonide and progesterone.
[0138] The corticosteroid drugs in the present invention include but are not limited to the above drugs.
[0139] In order to help to more clearly understand the present invention, the technical solution of the present invention will be further described below in conjunction with embodiments.
[0140] Example 1
[0141]
[0142] At room temperature, 200 mL of 75% ethanol, 9.8 g of potassium carbonate and 11 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-1 and 4.3 g of AIBI were added to the reaction bottle in sequence, and the temperature was raised to 70 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.2 g of compound II-1 solid, with a yield of 92.3% and a purity of 96.8%.
[0143] Example 2
[0144]
[0145] At room temperature, 200 mL of 2-methyltetrahydrofuran, 9 g of sodium carbonate, 9.9 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-2 and 3.3 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 65 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.2 g of compound II-2 solid, with a yield of 91.5% and a purity of 96.5%.
[0146] Example 3
[0147]
[0148] At room temperature, 160 mL of n-butanol, 13 mL of 33% sodium hydroxide solution, 9.9 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-3 and 2.5 g of CABN were added to the reaction bottle in sequence, and the temperature was raised to 80 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.3 g of compound II-3 solid, with a yield of 93.4% and a purity of 97.0%.
[0149] Example 4
[0150]
[0151] At room temperature, 100 mL of isopropanol, 7.5 mL of N,N-diisopropylethylamine, 9.2 mL of cyclohexene, 20 g of compound I-4 and 2.5 g of ACCN were added to the reaction bottle in sequence, and the temperature was raised to 75 °C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 13.2 g of compound II-4 solid, with a yield of 81.2% and a purity of 89.5%.
[0152] Example 5
[0153]
[0154] At room temperature, 160 mL of 2-methyltetrahydrofuran, 2.6 mL of formic acid, 4.4 g of ammonium formate, 20 g of compound I-5 and 3.3 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 70 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.0 g of compound II-5 solid, with a yield of 83.0% and a purity of 89.7%.
[0155] Example 6
[0156]
[0157] At room temperature, 160 mL of 95% ethanol, 6.9 g of potassium carbonate, 11 g of sodium hypophosphite, 20 g of compound I-6 and 5.4 g of AIBI were added to the reaction bottle in sequence, and the temperature was raised to 70 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.7 g of compound II-6 solid, with a yield of 93.3% and a purity of 97.7%.
[0158] Example 7
[0159]
[0160] At room temperature, 200 mL of isopropanol, 11 g of sodium bicarbonate, 6.8 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-7 and 4.2 g of AIBI were added to the reaction bottle in sequence, and the temperature was raised to 75 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.8 g of compound II-7 solid, with a yield of 94.3% and a purity of 95.8%.
[0161] Example 8
[0162]
[0163] At room temperature, 100 mL of isopropanol, 2.4 g of sodium carbonate, 26 g of triphenylsilane, 20 g of compound I-8 and 2.6 g of AIBN were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 13.6 g of compound II-8 solid, with a yield of 82.3% and a purity of 90.3%.
[0164] Example 9
[0165]
[0166] At room temperature, 200 mL of 2-methyltetrahydrofuran, 9 g of potassium carbonate, 8.7 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-9 and 3.5 g of ACCN were added to the reaction bottle in sequence, and the temperature was raised to 70 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.2 g of compound II-9 solid, with a yield of 85.3% and a purity of 90.8%.
[0167] Example 10
[0168]
[0169] At room temperature, 200 mL of isopropanol, 7.5 mL of 40% hydrazine hydrate, 20 g of compound I-10 and 3.4 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 75°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 12.6 g of compound II-10 solid, with a yield of 81.3% and a purity of 86.7%.
[0170] Embodiment 11
[0171]
[0172] At room temperature, 400 mL of tetrahydrofuran, 7.5 mL of triethylamine, 22 g of triphenylsilane, 20 g of compound I-11 and 1.6 g of AIBN were added to the reaction bottle in sequence, and the temperature was raised to 50°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 13.8 g of compound II-11 solid, with a yield of 81.3% and a purity of 89.3%.
[0173] Example 12
[0174]
[0175] At room temperature, 140 mL of 70% ethanol, 12 mL of triethylamine, 9.3 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-12 and 3.6 g of AIBI were added to the reaction bottle in sequence, and the temperature was raised to 70 ° C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.3 g of compound II-12 solid, with a yield of 90.3% and a purity of 94.8%.
[0176] Embodiment 13
[0177]
[0178] At room temperature, 200 mL of isopropanol, 6.7 g of sodium carbonate and 9.7 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-13 and 3.3 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 17.1 g of compound II-13 solid, with a yield of 92.5% and a purity of 95.5%.
[0179] Embodiment 14
[0180]
[0181] At room temperature, 100 mL of n-butanol, 18 mL of ammonia water, 9.6 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-14 and 2.1 g of CABN were added to the reaction bottle in sequence, and the temperature was raised to 85°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.5 g of compound II-14 solid, with a yield of 93.4% and a purity of 96.6%.
[0182] Embodiment 15
[0183]
[0184] At room temperature, 200 mL of 95% ethanol, 8 mL of ammonia water, 8.4 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-15 and 2.1 g of CABN were added to the reaction bottle in sequence, and the temperature was raised to 70°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.9 g of compound II-15 solid, with a yield of 93.8% and a purity of 97.5%.
[0185] Example 16
[0186]
[0187] At room temperature, 200 mL of isopropanol, 3.5 mL of triethylamine, 13 mL of cyclohexene, 20 g of compound I-16 and 2.6 g of ACVA were added to the reaction bottle in sequence, and the temperature was raised to 75°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.0 g of compound II-16 solid, with a yield of 92.2% and a purity of 96.5%.
[0188] Embodiment 17
[0189]
[0190] At room temperature, 100 mL of isopropanol, 6 mL of triethylamine, 13 mL of cyclohexene, 20 g of compound I-17 and 2.5 g of ACVA were added to the reaction bottle in sequence, and the temperature was raised to 75°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 15.7 g of compound II-17 solid, with a yield of 94.5% and a purity of 95.5%.
[0191] Embodiment 18
[0192]
[0193] At room temperature, 400 mL of isopropanol, 7.8 g of sodium carbonate and 12 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-18 and 4.0 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 16.8 g of compound II-18 solid, with a yield of 92.6% and a purity of 97.1%.
[0194] Embodiment 19
[0195]
[0196] At room temperature, 400 mL of isopropanol, 6.9 g of sodium carbonate, 12 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-19 and 5.1 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.9 g of compound II-19 solid, with a yield of 91.6% and a purity of 94.9%.
[0197] Embodiment 20
[0198]
[0199] At room temperature, 200 mL of isopropanol, 6.9 g of sodium carbonate, 12 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-20 and 2.0 g of AIBA were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.8 g of compound II-20 solid, with a yield of 91.6% and a purity of 96.1%.
[0200] Embodiment 21
[0201]
[0202] At room temperature, 200 mL of 95% ethanol, 11 mL of triethylamine, 8.4 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-21 and 1.9 g of AIBN were added to the reaction bottle in sequence, and the temperature was raised to 70°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.2 g of compound II-21 solid, with a yield of 83.8% and a purity of 90.5%.
[0203] Embodiment 22
[0204]
[0205] At room temperature, 140 mL of isopropanol, 168 mL of triethylamine, 89 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-22 and 3.3 g of AIBN were added to the reaction bottle in sequence, and the temperature was raised to 80°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 12.6 g of compound II-22 solid, with a yield of 75.2% and a purity of 85.0%.
[0206] Embodiment 23
[0207]
[0208] At room temperature, 120 mL of DMF, 5.8 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-23 and 1.4 g of ABVN were added to the reaction bottle in sequence, and the temperature was raised to 90°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.0 g of compound II-23 solid, with a yield of 81.5% and a purity of 90.3%.
[0209] Embodiment 24
[0210]
[0211] At room temperature, 120 mL of ethyl acetate, 7.2 mL of 50% hypophosphorous acid aqueous solution, 20 g of compound I-24 and 1.7 g of AIBME were added to the reaction bottle in sequence, and the temperature was raised to 40°C for reaction. TLC was performed until there was no raw material. After post-treatment, the precipitated solid was filtered and dried to obtain 14.1 g of compound II-24 solid, with a yield of 82.3% and a purity of 89.6%.
[0212] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for dehalogenating a 9-halogenated steroid compound, It is characterized in that The method comprises the following steps: a compound I reacts with a hydrogen donor and an azo free radical initiator, and an organic base and / or an inorganic base are added to react in a solvent to obtain a 9-halogenated steroid compound 9-position dehalogenation product compound II, and the reaction formula is as follows: Wherein, R1, R2, R3, R4 and R5 shown in the structural formula of compound I and compound II are selected independently of each other, and: R1=H or methyl; R2=H, OH or methyl; R3=H or OH; R4=CH2R9, R9=H, OH or OCOR10, R10 is an alkyl group with less than six carbon atoms; R5=O, OH, OCOCF3 or OCOR12, R12 is H or methyl; X=Cl or Br; Dashed lines are single or double bonds; Wherein, the azo free radical initiator is selected from one or a combination of azobisisobutyronitrile, azobisisoheptanenitrile, azobiscyclohexylcarbonitrile, dimethyl azobisisobutyrate, azobisisopropylimidazoline hydrochloride or azobiscyanovaleric acid; The hydrogen donor is one or a combination of hypophosphorous acid and hypophosphite, organosilicon hydride, hydrazine compound or cyclohexene; The solvent is one or a combination of C1-C6 alcohols, tetrahydrofuran, 2-methyltetrahydrofuran, N,N-dimethylformamide or ethyl acetate, or a mixture thereof with water; The organic base is selected from one or a combination of diethylamine, triethylamine, tert-butylamine, pyridine or N,N-diisopropylethylamine; the inorganic base is selected from one or a combination of ammonia water, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide; The molar ratio of the compound I, the azo free radical initiator and the hydrogen donor is 1:(0.15-0.4):(1.5-3).
2. The method for dehalogenating a 9-halogenated steroid compound according to any one of claim 1, It is characterized in that The hypophosphite is selected from sodium hypophosphite and / or potassium hypophosphite; and / or, the organosilicon hydride is selected from triphenylsilane; And / or, the hydrazine compound is selected from hydrazine and / or hydrazine hydrate.
3. The method for dehalogenating a 9-halogenated steroid compound according to claim 1, It is characterized in that The azo free radical initiator is selected from one or a combination of azobisisobutylimidazole hydrochloride or azobiscyanovaleric acid.
4. The dehalogenation method of a 9-halogenated steroid compound according to any one of claims 1 to 3, It is characterized in that The method comprises the following steps: adding compound I, a hydrogen donor and an azo free radical initiator into a solvent, reacting at 40-90° C. to obtain a 9-halogenated steroid compound 9-position dehalogenation product compound II.
5. The method for dehalogenating a 9-halogenated steroid compound according to claim 1, It is characterized in that The reaction temperature is 50-85°C.
6. The method for dehalogenating a 9-halogenated steroid compound according to claim 1, It is characterized in that The inorganic base is selected from one or a combination of ammonia water, sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide.
7. The method for dehalogenating a 9-halogenated steroid compound according to claim 1, It is characterized in that The solvent is selected from a mixture of C1-C6 alcohols and water.
